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Introduction:
Diagnosis and treatment of cardiac and circulatory dysfunction can be error-prone and relies heavily on clinical 
intuition and experience. Model-based approaches utilising measurements available in the Intensive care unit 
(ICU) can provide a clearer physiological picture of a patient’s cardiovascular status to assist medical staff with 
diagnosis and therapy decisions. This research tests a subject-specific cardiovascular system (CVS) modelling 
technique on measurements from a porcine model of acute pulmonary embolism (APE). 
Methods:
Measurements were recorded in 5 pig trials, where autologous blood clots were inserted every two hours into 
the jugular vein to simulate pulmonary emboli. Of these measurements only a minimal set of clinically available or 
inferable data were used in the identification process (aortic and pulmonary artery pressure, stroke volume, heart 
rate, global end diastolic volume, and mitral and tricuspid valve closure times).
The CVS model was fitted to 46 sets of data taken at 30 minute intervals (t=0, 30, 60, …, 270) during the induction 
of APE to identify physiological model parameters and their change over time in APE. Model parameters and 
outputs were compared to experimentally derived metrics and measurements not used in the identification 
method to validate the accuracy of the model and assess its diagnostic capability. 
Results:
Modelled mean ventricular volumes and maximum ventricular pressures matched measured values with median 
absolute errors of 4.3% and 4.4%, which are less than experimental measurement noise (~10%). An increase in 
pulmonary vascular resistance, the main hemodynamic consequence of APE, was identified in all the pigs and 
related well to experimental values (R=0.68). Detrimental changes in reflex responses, such as decreased right 
ventricular contractility, were noticed in two pigs that died during the trial, diagnosing the loss of autonomous 
control. Increases in the ratio of the modelled right to left ventricular end diastolic volumes, signifying the 
leftward shift of the intra-ventricular septum seen in APE, compared well to the clinically measured index 
(R=0.88). 
Conclusions:
Subject-specific CVS models can accurately and continuously diagnose and track acute disease dependent 
cardiovascular changes resulting from APE using readily available measurements. Human trials are underway to 
clinically validate these animal trial results. 
